cysteine has been researched along with Liver Dysfunction in 59 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 33 (55.93) | 18.7374 |
1990's | 6 (10.17) | 18.2507 |
2000's | 10 (16.95) | 29.6817 |
2010's | 6 (10.17) | 24.3611 |
2020's | 4 (6.78) | 2.80 |
Authors | Studies |
---|---|
Bakers, FCH; Brouwers, MCGJ; Dagnelie, PC; Elshorbagy, AK; Eussen, SJPM; Jansen, JFA; Kooi, ME; Kusters, YHAM; Meex, SJR; Olsen, T; Refsum, H; Retterstøl, K; Schalkwijk, CG; Stehouwer, CDA; Tore, EC; van Greevenbroek, MMJ; Vinknes, KJ | 1 |
Iwanaga, S; Kaneko, I; Murata, Y; Nishi, T; Okubo, K; Yuda, M | 1 |
Capelletti, MM; Manceau, H; Peoc'h, K; Puy, H | 1 |
Bertolo, RF; Brown, RJ; Karthigesu, K | 1 |
Ancy, I; Chitra, L; Kumaradhas, P; Palvannan, T; Ratha, P | 1 |
Aguilar-Delfín, I; Díaz-Muñoz, M; García-García, N; Hernández-Muñoz, R; Olguín-Martínez, M; Sánchez-Sevilla, L | 1 |
Anilkumar, N; Brandes, RP; Brewer, AC; Burr, S; Caldwell, A; Dew, T; Dong, X; Halket, J; Hughes, RD; Martin, D; Mistry, RK; Murray, TV; Quaglia, A; Sawyer, GJ; Schröder, K; Shah, AM; Sherwood, R | 1 |
Chen, G; Hu, XY; Liu, JL; Liu, XY; Luo, JX; Nie, HM; Wen, DC; Zhang, Y | 1 |
Lin, CC; Liu, WH; Yin, MC | 1 |
Briceño, J; Corrales, FJ; De La Mata, M; Ferrín, G; Gómez, MA; González, R; Hidalgo, AB; López-Cillero, P; López-Sánchez, LM; Muñoz-Castañeda, JR; Muntané, J; Ranchal, I; Rodríguez-Ariza, A | 1 |
FOLLIS, RH; HANDLER, P | 1 |
Cheng, J; Gonzalez, FJ; Idle, JR; Krausz, KW; Ma, X | 1 |
Darwiche, H; Oh, SH; Petersen, BE; Pintilie, DG; Salganik, SV; Shupe, TD | 1 |
LAZAROW, A; PAPAY, SL | 1 |
LAZAROW, A; PALAY, SL | 1 |
He, C; Tang, C; Yin, C; Yin, L | 1 |
BEVERIDGE, JM; McLEAN, JR | 1 |
SCHWARZ, K | 1 |
TRUTSCHEL, W | 1 |
GERSHBEIN, LL | 1 |
LEUKERT, G; ZICHA, L | 1 |
CAZZOLA, D | 1 |
MORSE, BS; NUSSBAUM, M | 1 |
FREITAS, PA | 1 |
CHIYOTANI, K | 1 |
SCHULZE, G | 1 |
Farzaneh-Far, R; Moore, K | 1 |
FRIEDBERG, V; KIRNBERGER, E | 1 |
Chijiiwa, K; Kuroki, S; Shimada, K; Takamatsu, Y; Tanaka, M; Yamaguchi, K | 1 |
Bass, D; Berry, G; DiDomenico, P; Fridge, J; Sarwal, M | 1 |
Cohen, SD; Dominick, PK; Roberts, JC; Slitt, AM | 1 |
Ando, M; Gondo, T; Hidaka, I; Hino, K; Korenaga, M; Nishina, S; Okuda, M; Sakaida, I | 1 |
Linden, CH; Rumack, BH | 1 |
Wu, CH; Wu, GY | 1 |
Castro, JA; de Fenos, OM; de Ferreyra, EC | 1 |
Dudley, RE; Klaassen, CD | 1 |
Fleming, JF; Miquel, J; Weber, HU | 1 |
Ando, N; Fukutani, C; Kitano, Y; Motokura, H; Uenishi, N; Uete, T | 1 |
Motokura, H; Uete, T | 1 |
Buchholz, U; Fukui, H; Hafkemeyer, P; Keppler, A; Keppler, D; Kojima, H; Tsujii, T; Uemura, M | 1 |
Davies, MH; Elias, E; Klovrza, L; Waring, RH | 1 |
Itakura, Y; Kasuga, S; Matsura, T; Sumioka, I; Yamada, K | 1 |
Marx, JJ; Swinkels, DW | 1 |
Chen, TS; Ray, MB; Srinivasan, C; Williams, WM | 1 |
Hayashi, H; Ikeda, R; Imaizumi, Y; Kawanaka, M; Sanae, F; Shiono, Y; Takikawa, T; Wakusawa, S; Yamada, G; Yano, M; Yoshioka, K | 1 |
Hirsch, W; Smerlings, H | 1 |
Dow, J; Macdonald, CM; Moore, MR | 1 |
Hart, FE; Willson, RA | 1 |
Davis, M; Harrison, NG; Simmons, CJ; Williams, R | 1 |
Foberg, U; Fryden, A; Mårtensson, J; Schwartz, MK; Sörbo, B; Weiland, O | 1 |
Butterworth, M; Cohen, GM; Smith, LL; Upshall, DG | 1 |
Nakagawa, Y | 1 |
Yamada, Z | 1 |
Broch, E; Gaudiano, A; Netkovszky, K; Petti, G; Polizzi, M; Severini, G | 1 |
Bogenhard, H | 1 |
Dressel, H; Richter, J | 1 |
Akahoshi, M; Hashimoto, T; Itsuno, Y; Kanda, M | 1 |
Nakazawa, S; Yamada, K; Yamada, Z | 1 |
Yamada, K; Yamada, Z | 1 |
6 review(s) available for cysteine and Liver Dysfunction
Article | Year |
---|---|
Ferroptosis in Liver Diseases: An Overview.
Topics: alpha-Tocopherol; Animals; Autophagy; Chemical and Drug Induced Liver Injury; Cyclohexylamines; Cysteine; Ferroptosis; Glutathione; Heme; Humans; Iron; Kelch-Like ECH-Associated Protein 1; Lipid Peroxidation; Lipoxygenase; Liver Diseases; Liver Neoplasms; Oxidative Stress; Phenylenediamines; Phospholipid Hydroperoxide Glutathione Peroxidase; Piperazines; Quinoxalines; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; Sorafenib; Spiro Compounds; Sulfasalazine; Tumor Suppressor Protein p53 | 2020 |
Parenteral Nutrition and Oxidant Load in Neonates.
Topics: Antioxidants; Atrophy; Cysteine; Enteral Nutrition; Glutathione; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Lipid Peroxidation; Liver Diseases; Oxidants; Oxidative Stress; Parenteral Nutrition; Parenteral Nutrition, Total; Premature Birth; Reactive Oxygen Species; Vitamins | 2021 |
Cysteinyl-leukotrienes and the liver.
Topics: Animals; Cholestasis; Cysteine; Hepatorenal Syndrome; Humans; Leukotrienes; Liver; Liver Diseases; Signal Transduction | 2003 |
Acetaminophen overdose.
Topics: Acetaminophen; Acetylcysteine; Adult; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Biotransformation; Chemical and Drug Induced Liver Injury; Child; Cysteine; Dose-Response Relationship, Drug; Glutathione; History, 20th Century; Humans; Kinetics; Liver Diseases; Prognosis; Prothrombin Time; Time Factors | 1984 |
Thiazolidine-4-carboxylic acid, a physiologic sulfhydryl antioxidant with potential value in geriatric medicine.
Topics: Aged; Animals; Antioxidants; Chemical Phenomena; Chemistry; Cysteine; Dogs; Drug Combinations; Folic Acid; Gastrointestinal Diseases; Humans; Liver Diseases; Longevity; Mice; Rats; Thiazoles; Thiazolidines | 1982 |
[Diagnosis and treatment of primary hemochromatosis].
Topics: Cysteine; Female; Ferritins; Genetic Testing; Hemochromatosis; Homozygote; Humans; Liver Diseases; Liver Function Tests; Male; Mutation; Phlebotomy; Transferrin; Tyrosine | 1999 |
2 trial(s) available for cysteine and Liver Dysfunction
Article | Year |
---|---|
[Drug therapy of liver diseases with Hepatofalk].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Cysteine; Drug Combinations; Female; Folic Acid; Humans; Liver Diseases; Liver Function Tests; Male; Middle Aged; Niacinamide; Orotic Acid; Plant Extracts; Thiamine; Time Factors; Vitamin B 12 | 1976 |
[On the diagnosis and therapy of chronic hepatopathies. Experiences with Orgatract].
Topics: Clinical Trials as Topic; Cysteine; Humans; Liver Diseases; Liver Extracts; Orotic Acid; Pyridoxine | 1965 |
51 other study(ies) available for cysteine and Liver Dysfunction
Article | Year |
---|---|
Associations between plasma sulfur amino acids and specific fat depots in two independent cohorts: CODAM and The Maastricht Study.
Topics: Adipose Tissue; Adiposity; Amino Acids, Sulfur; Body Mass Index; Chromatography, Liquid; Cross-Sectional Studies; Cysteine; Female; Humans; Intra-Abdominal Fat; Liver Diseases; Male; Methionine; Obesity; Tandem Mass Spectrometry | 2023 |
Plasmodium 6-cysteine proteins determine the commitment of sporozoites to liver-infection.
Topics: Animals; Cysteine; Hepatocytes; Humans; Liver Diseases; Plasmodium; Protozoan Proteins; Sporozoites | 2023 |
New amino acid-Schiff base derived from s-allyl cysteine and methionine alleviates carbon tetrachloride-induced liver dysfunction.
Topics: Animals; Antioxidants; Binding Sites; Carbon Tetrachloride Poisoning; Catalytic Domain; Cysteine; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Hepatocytes; Imines; Liver Diseases; Male; Molecular Docking Simulation; Oxidative Stress; Rats | 2017 |
Oxidant status and lipid composition of erythrocyte membranes in patients with type 2 diabetes, chronic liver damage, and a combination of both pathologies.
Topics: Case-Control Studies; Cholesterol; Cysteine; Diabetes Mellitus, Type 2; Erythrocyte Membrane; Humans; Lipids; Liver Cirrhosis; Liver Diseases; Nitric Oxide; Nitrites; Oxidants; Oxidation-Reduction; Oxidative Stress; Phospholipids; Thiobarbituric Acid Reactive Substances | 2013 |
NADPH oxidase 4 regulates homocysteine metabolism and protects against acetaminophen-induced liver damage in mice.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Betaine; Blotting, Western; Cells, Cultured; Cysteine; Female; Glutathione; Hep G2 Cells; Homocysteine; Humans; Immunoenzyme Techniques; Liver; Liver Diseases; Methionine; Mice; Mice, Knockout; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species; S-Adenosylmethionine | 2015 |
Aqueous extract from Aconitum carmichaelii Debeaux reduces liver injury in rats via regulation of HMGB1/TLR4/NF-ΚB/caspase-3 and PCNA signaling pathways.
Topics: Aconitum; Animals; Caspase 3; Cysteine; Drug Combinations; Galactosamine; Glycine; Glycyrrhetinic Acid; HMGB1 Protein; Liver; Liver Diseases; Male; NF-kappa B; Plant Extracts; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Signal Transduction; Toll-Like Receptor 4 | 2016 |
Alleviative effects of s-allyl cysteine and s-ethyl cysteine on MCD diet-induced hepatotoxicity in mice.
Topics: Animals; Antioxidants; Catalase; Chemical and Drug Induced Liver Injury; Cholesterol; Choline; Choline Deficiency; Cysteine; Diet; Fatty Acid Synthases; Glucosephosphate Dehydrogenase; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Interleukin-1beta; Interleukin-6; Liver; Liver Diseases; Malate Dehydrogenase; Male; Malondialdehyde; Methionine; Mice; Mice, Inbred C57BL; Random Allocation; Superoxide Dismutase; Triglycerides; Tumor Necrosis Factor-alpha | 2008 |
Alteration of S-nitrosothiol homeostasis and targets for protein S-nitrosation in human hepatocytes.
Topics: Adult; Aged; Aldehyde Oxidoreductases; Analysis of Variance; Biotin; Chromatography, Liquid; Cysteine; Female; Hepatocytes; Homeostasis; Humans; Liver Diseases; Male; Middle Aged; Nitric Oxide; Nitrosation; Phosphatidylethanolamine Binding Protein; Protein Disulfide-Isomerases; Proteins; S-Nitrosothiols; Tandem Mass Spectrometry; Tumor Cells, Cultured | 2008 |
The role of thyroid activity in the pathogenesis of hepatic lesions due to choline and cystine deficiency.
Topics: Choline; Choline Deficiency; Cysteine; Cystine; Gastrointestinal Diseases; Liver; Liver Diseases; Thyroid Gland | 1948 |
Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity.
Topics: Acetaminophen; Alanine Transaminase; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Biomarkers; Biotransformation; Chemical and Drug Induced Liver Injury; Cysteine; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Induction; Glutathione; Humans; Hydrogen Peroxide; Liver; Liver Diseases; Lysophosphatidylcholines; Male; Metabolomics; Mice; Mice, Knockout; Mice, Transgenic; Necrosis; Oxidative Stress; Pregnane X Receptor; Principal Component Analysis; Receptors, Steroid; Rifampin; RNA, Messenger; Time Factors | 2009 |
Hepatic stellate cells' involvement in progenitor-mediated liver regeneration.
Topics: 2-Acetylaminofluorene; alpha-Fetoproteins; Animals; Connective Tissue Growth Factor; Cysteine; Hepatectomy; Hepatic Stellate Cells; Liver; Liver Diseases; Liver Regeneration; Male; Rats; Rats, Inbred F344; Stem Cells; Transforming Growth Factor beta | 2010 |
Protection against diabetes and production of hepatic necrosis by use of cysteine and alloxan in the rat.
Topics: Alloxan; Animals; Cysteine; Diabetes Mellitus; Liver; Liver Diseases; Necrosis; Rats | 1946 |
The production of ascites and liver necrosis following the injection of alloxan plus cysteine.
Topics: Alloxan; Animals; Ascites; Cysteine; Injections; Liver; Liver Diseases; Necrosis | 1946 |
Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages.
Topics: Acute Disease; Administration, Oral; Animals; Caco-2 Cells; Chitosan; Cysteine; Gene Silencing; Humans; Inflammation; Liver; Liver Diseases; Macrophages; Male; Mice; Mice, Inbred C57BL; Nanoconjugates; Nanoparticles; Polymers; RNA, Small Interfering; Tumor Necrosis Factor-alpha | 2013 |
The prevention of liver necrosis by alpha-tocopherol, methionine, and cysteine by oral and parenteral routes.
Topics: alpha-Tocopherol; Cysteine; Humans; Liver Diseases; Methionine; Vitamin E | 1953 |
Factors protecting against dietary necrotic liver degeneration.
Topics: Cysteine; Cystine; Humans; Liver Diseases; Metabolic Diseases; Methionine; Necrosis | 1954 |
[Comparative studies on intravenous & oral reducdyn treatment of acute & chronic liver diseases].
Topics: Administration, Intravenous; Administration, Oral; Cysteine; Fructose; Humans; Liver Diseases; Thiophenes | 1958 |
Effect of DL-ethionine and S-ethyl-L-cysteine on rat liver regeneration.
Topics: Animals; Cysteine; Ethionine; Liver; Liver Diseases; Liver Regeneration; Rats; Regeneration; Sodium; Sodium, Dietary | 1958 |
[The influence of 1-cysteine, d, 1-homocysteine thiolactone and d-fructose on the 17-ketosteroid fractions in the urine of patients with liver diseases].
Topics: 17-Ketosteroids; Body Fluids; Cysteine; Fructose; Homocysteine; Humans; Liver Diseases; Organic Chemicals | 1959 |
[On the treatment of the premenstrual syndrome and menstruation disorders by means of hepatic therapy].
Topics: Cysteine; Female; Gluconates; Humans; Liver Diseases; Liver Extracts; Menstruation Disturbances; Methionine; Niacin; Niacinamide; Premenstrual Syndrome; Thioctic Acid; Vitamin B 12; Vitamin B Complex | 1963 |
PLASMA FIBRIN STABILIZING FACTOR ACTIVITY IN VARIOUS DISEASES.
Topics: Alpha-Globulins; Anemia; Biological Assay; Biomedical Research; Blood Coagulation; Blood Coagulation Factors; Calcium; Collagen Diseases; Cysteine; Factor XIII; Fibrin; Hemorrhagic Disorders; Humans; Leukemia; Liver; Liver Diseases; Lymphoma; Neoplasms; Pathology; Serum Globulins; Sulfhydryl Compounds; Thrombin | 1964 |
[THERAPY OF ACUTE AND CHRONIC HEPATIC DISEASES WITH THE DRUG ASSOCIATION, HOMOCYSTEINE-THIOLACTONE, CYSTEINE AND FRUCTOSE].
Topics: Chemical and Drug Induced Liver Injury; Cysteine; Fructose; Hepatitis; Hepatitis A; Hepatitis B virus; Homocysteine; Humans; Lactones; Liver Cirrhosis; Liver Diseases | 1963 |
[STUDIES ON METHIONINE METABOLISM. 4. ON THE METABOLISM OF CYSTINE AND CYSTEINE].
Topics: Adolescent; Amino Acids; Blood Chemical Analysis; Cysteine; Cystine; Humans; Liver Diseases; Methionine; Tuberculosis; Urine | 1963 |
[Comparative studies on the enzyme activity in rat liver and serum after experimental liver damage by carbon tetrachloride and under the effect of cysteine-acetylhomocysteine thiolactone].
Topics: Abdominal Injuries; Animals; Carbon Tetrachloride; Cysteine; Enzymes; Lactones; Liver; Liver Diseases; Rats | 1960 |
[Functional liver disorders and their treatment in pregnancy hyperemesis].
Topics: Cysteine; Female; Humans; Hyperemesis Gravidarum; Liver Diseases; Methionine; Pregnancy; Pregnancy Complications | 1951 |
Role of leukotrienes on hepatic ischemia/reperfusion injury in rats.
Topics: Alanine Transaminase; Animals; Arachidonate 5-Lipoxygenase; Cysteine; Edema; Epoxide Hydrolases; Glutathione Transferase; Leukotriene B4; Leukotrienes; Liver; Liver Circulation; Liver Diseases; Lung; Male; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger | 2004 |
Noncirrhotic portal hypertension in association with juvenile nephropathic cystinosis: case presentation and review of the literature.
Topics: Adult; Biopsy; Creatinine; Cysteamine; Cysteine; Cystinosis; Female; Humans; Hypertension, Portal; Kidney Transplantation; Kupffer Cells; Liver; Liver Diseases; Tomography, X-Ray Computed | 2004 |
Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion.
Topics: Acetaminophen; Animals; Blood Urea Nitrogen; Buthionine Sulfoximine; Chemical and Drug Induced Liver Injury; Cysteine; Glutathione; In Vitro Techniques; Kidney; Kidney Diseases; L-Iditol 2-Dehydrogenase; Liver; Liver Diseases; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Prodrugs; Protective Agents; Thiazoles; Thiazolidines | 2005 |
Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein.
Topics: Alanine Transaminase; Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cysteine; Cytochrome P-450 CYP2E1; Disease Models, Animal; Drug Combinations; Glutamate-Cysteine Ligase; Glutathione; Glycine; Glycyrrhetinic Acid; Hepacivirus; Liver; Liver Diseases; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria, Liver; Oxidative Stress; Polyproteins; RNA, Messenger; Viral Proteins | 2007 |
Effect of 2-aminoethyl-L-cysteine on collagen accumulation in isolated hepatic granulomas.
Topics: Animals; Collagen; Cysteine; Dose-Response Relationship, Drug; Female; Granuloma; Hydroxylation; Hydroxyproline; Liver; Liver Diseases; Lysine; Mice; Proline; Schistosomiasis | 1983 |
Tryptophan potentiation of the late cysteine preventive effects in carbon tetrachloride-induced necrosis.
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Cysteine; Drug Synergism; Liver Diseases; Male; Necrosis; Rats; Rats, Inbred Strains; Time Factors; Tryptophan | 1983 |
Changes in hepatic glutathione concentration modify cadmium-induced hepatotoxicity.
Topics: Alanine; Animals; Aspartic Acid; Cadmium Poisoning; Chemical and Drug Induced Liver Injury; Cysteine; Drug Synergism; Glutathione; Ketones; L-Iditol 2-Dehydrogenase; Liver; Liver Diseases; Male; Maleates; Rats; Rats, Inbred Strains; Transaminases; Triglycerides | 1984 |
Comparison of substrates for measuring cystyl-amino peptidase activity in serum of pregnancy and hepatic disease and in various tissues.
Topics: 2-Naphthylamine; Amides; Aminopeptidases; Cysteine; Cystine; Cystinyl Aminopeptidase; Estriol; Female; Humans; Hydrogen-Ion Concentration; Liver Diseases; Pregnancy; Substrate Specificity | 1981 |
[Evaluation of substrates for measuring cystyl-amino peptidase activity in various sera and tissues with respect to L-cystine-di-beta-naphthylamide, L-cystine-bis-p-nitroanilide, L-cysteine-beta-naphthylamide, and S-benzyl-L-cysteine-p-nitroanilide (autho
Topics: Amides; Aminopeptidases; Anilides; Animals; Cysteine; Cystine; Cystinyl Aminopeptidase; Female; Humans; Kidney; Liver; Liver Diseases; Placenta; Pregnancy; Rats; Substrate Specificity | 1980 |
Cysteinyl leukotrienes in the urine of patients with liver diseases.
Topics: Adult; Aged; Bilirubin; Cholestasis; Cholestasis, Intrahepatic; Chromatography, High Pressure Liquid; Creatinine; Cysteine; Drainage; Female; Humans; Leukotriene E4; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Radioimmunoassay; Regression Analysis | 1994 |
Plasma cysteine and sulphate levels in patients with cirrhosis of the liver.
Topics: Adult; Critical Care; Cysteine; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Male; Methylation; Middle Aged; Sulfates | 1994 |
Mechanisms of protection by S-allylmercaptocysteine against acetaminophen-induced liver injury in mice.
Topics: Acetaminophen; Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Coenzymes; Cysteine; Cytochrome P-450 CYP2E1; Glucuronosyltransferase; Glutathione; Lipid Peroxidation; Liver; Liver Diseases; Male; Mice; Proteins; Sulfhydryl Compounds; Sulfotransferases; Ubiquinone; Vitamin E | 1998 |
Prevention of acetaminophen-induced liver toxicity by 2(R,S)-n-propylthiazolidine-4(R)-carboxylic acid in mice.
Topics: Acetaminophen; Aldehydes; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Cysteine; Dose-Response Relationship, Drug; Drug Interactions; Glutathione; Glutathione Disulfide; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Prodrugs; Protective Agents; Thiazoles | 2001 |
C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan.
Topics: Adult; Asian People; Aspartic Acid; Cysteine; Female; Hemochromatosis; Hemochromatosis Protein; Hepatitis C, Chronic; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Humans; Iron Overload; Japan; Liver Diseases; Male; Membrane Proteins; Middle Aged; Point Mutation; Polymerase Chain Reaction; Tyrosine | 2001 |
A possible protective role for sulphydryl compounds in acute alcoholic liver injury.
Topics: Acetaldehyde; Alcoholic Intoxication; Animals; Chemical and Drug Induced Liver Injury; Cysteine; Dose-Response Relationship, Drug; Ethanol; Glutathione; Humans; Liver; Liver Diseases; Male; Mercaptoethylamines; Methionine; Mice; Sulfhydryl Compounds; Time Factors | 1977 |
In vitro spectral alteration of hepatic cytochrome P-450 by experimental drug injury.
Topics: Acetaminophen; Animals; Buffers; Chemical and Drug Induced Liver Injury; Cysteamine; Cysteine; Cytochrome P-450 Enzyme System; Dimethyl Sulfoxide; Enzyme Induction; Glutathione; In Vitro Techniques; Liver Diseases; Male; Methionine; Microsomes, Liver; Phenobarbital; Rats; Solvents | 1977 |
Paracetamol overdose in man: relationship between pattern of urinary metabolites and severity of liver damage.
Topics: Acetaminophen; Acetylcysteine; Chemical and Drug Induced Liver Injury; Cysteine; Female; Glucuronates; Humans; Liver Diseases; Male; Suicide; Sulfates | 1976 |
Sulfur amino acid metabolism in hepatobiliary disorders.
Topics: Adolescent; Adult; Aged; Amino Acids, Sulfur; Cholestasis; Cysteine; Female; Gilbert Disease; Hepatic Encephalopathy; Hepatitis, Viral, Human; Humans; Liver Cirrhosis, Alcoholic; Liver Diseases; Male; Methionine; Middle Aged | 1992 |
Cysteine isopropylester protects against paracetamol-induced toxicity.
Topics: Acetaminophen; Alanine Transaminase; Animals; Aspartate Aminotransferases; Benzo(a)pyrene; Chemical and Drug Induced Liver Injury; Cysteine; Cytochrome P-450 Enzyme System; Glutathione; Kidney; Liver Diseases; Lung; Male; Mice; Mice, Inbred BALB C; Spleen; Sulfhydryl Compounds | 1992 |
Effects of buthionine sulfoximine and cysteine on the hepatotoxicity of butylated hydroxytoluene in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Buthionine Sulfoximine; Butylated Hydroxytoluene; Chemical and Drug Induced Liver Injury; Cysteine; Drug Interactions; Glutathione; Lethal Dose 50; Liver Diseases; Male; Methionine Sulfoximine; Rats; Rats, Inbred F344 | 1987 |
[Fibrinolysis activities and factor XIII in the neonatal period. 2. Relationship between factor XIII and fibrinolysis activities].
Topics: Animals; Cyclohexanecarboxylic Acids; Cysteine; Embryo, Mammalian; Factor XIII; Female; Fibrin; Fibrinolysin; Fibrinolysis; Humans; Infant, Newborn; Liver Diseases; Pregnancy; Rabbits | 1971 |
[Action of some drugs on experimental liver necrosis].
Topics: Animals; Chlorpromazine; Cysteine; Injections, Intraperitoneal; Ischemia; Liver Diseases; Necrosis; Rats; Tetracycline | 1971 |
[Biological evaluation of liver protective agents with special consideration of liver preparations. 9. Practical use of prepared methods for biological evaluation of commercial liver preparations].
Topics: Alcohols; Animals; Biological Assay; Cysteine; Dosage Forms; Injections, Intravenous; Liver Diseases; Liver Extracts; Rats; Vitamin B 12 | 1969 |
[The effect of various vitamines and cysteine on the experimental alcoholic hepatic injury].
Topics: Alcoholism; Animals; Chemical and Drug Induced Liver Injury; Cysteine; Fatty Acids; Humans; Liver; Liver Diseases; Male; Phosphates; Rats; Vitamins | 1969 |
[Clinical evaluation of active and potentially active form of factor XIII].
Topics: Adult; Carbon Tetrachloride; Child; Cysteine; Disseminated Intravascular Coagulation; Factor XIII; Humans; Infant; Infant, Newborn; Liver Diseases; Thrombin | 1970 |
Active and potentially active forms of fibrin stabilizing factor (factor 13) in various disorders and in neonatal infants.
Topics: Blood Coagulation Factors; Child; Child, Preschool; Cysteine; Factor XIII; Fibrinogen; Glutathione; Humans; Infant, Newborn; Liver Diseases | 1968 |